[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607817":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":42,"responsibleParty":60,"collaborators":25,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":25,"eligibilityCriteria":68,"healthyVolunteers":65,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":25,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":25,"overallStatus":44,"whyStopped":25,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Cairo University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"group number 1","EXPERIMENTAL","twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will bein group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.",[13],"Other: Buteyko breathing",{"label":15,"type":16,"description":17,"interventionNames":18},"group number 2","ACTIVE_COMPARATOR","Twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II oand this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.",[19],"Other: usual care",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Buteyko breathing","twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"usual care","twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.",[15],[31],{"name":32,"affiliation":5,"role":33},"Ali MA Ismail, lecturer","PRINCIPAL_INVESTIGATOR",[35,39],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","01005154209","ali.mohamed@pt.cu.edu.eg",{"name":40,"role":36,"phone":25,"phoneExt":25,"email":41},"Ali mohamed, lecturer","allooka2012@gmail.com",[43],{"facility":5,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Dokki","Giza Governorate","11432","Egypt","EG",{"type":51,"coordinates":52},"Point",[53,54],31.2113,30.03823,{"lat":54,"lon":53},[57],{"name":58,"role":36,"phone":59,"phoneExt":25,"email":38},"ali AM Ismail, lecturer","+201005154209",{"type":33,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Ali Mohamed Ali ismail","lecturer of physical therapy for Cardiovascular, Respiratory disorder and Geriatrics, Faculty of Physical Therapy, Cairo University","100607817","efficacy-of-buteyko-breathing-in-seniors-with-chronic-eustachian-tube-dysfunction-100607817",false,"NCT07193485","Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction","Inclusion Criteria:\n\n* Eustachian Tube Dysfunction (chronic obstructive form)\n* unilateral ear affetion\n* senior patients\n* chronci affection more than 3 months\n\nExclusion Criteria:\n\n* obesity\n* cardiac probelms repsiratory problems","ALL","65 Years","75 Years",{"count":73,"type":74},40,"ESTIMATED","INTERVENTIONAL",[77],"NA","Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective",[80],"Eustachian Tube Dysfunction","2025-09-18",{"date":83,"type":84},"2025-09-25","ACTUAL",{"date":86,"type":84},"2025-05-12",{"date":88,"type":74},"2025-10-10",{"name":5,"class":6},1]